Literature DB >> 12654297

Overexpression of transcription factor AP-2alpha suppresses mammary gland growth and morphogenesis.

J Zhang1, S Brewer, J Huang, T Williams.   

Abstract

AP-2 transcription factors are key regulators of mouse embryonic development. Aberrant expression of these genes has also been linked to the progression of human breast cancer. Here, we have investigated the role of the AP-2 gene family in the postnatal maturation of the mouse mammary gland. Analysis of AP-2 RNA and protein levels demonstrates that these genes are expressed in the mammary glands of virgin and pregnant mice. Subsequently, AP-2 expression declines during lactation and then is reactivated during involution. The AP-2alpha and AP-2gamma proteins are localized in the ductal epithelium, as well as in the terminal end buds, suggesting that they may influence growth of the ductal network. We have tested this hypothesis by targeting AP-2alpha expression to the mouse mammary gland using the MMTV promoter. Our studies indicate that overexpression of AP-2alpha inhibits mammary gland growth and morphogenesis, and this coincides with a rise in PTHrP expression. Alveolar budding is severely curtailed in transgenic virgin mice, while lobuloalveolar development and functional differentiation are inhibited during pregnancy and lactation, respectively. Our studies strongly support a role for the AP-2 proteins in regulating the proliferation and differentiation of mammary gland epithelial cells in both mouse and human.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654297     DOI: 10.1016/s0012-1606(02)00119-7

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  16 in total

1.  Generation and characterization of a novel neural crest marker allele, Inka1-LacZ, reveals a role for Inka1 in mouse neural tube closure.

Authors:  Bethany S Reid; Thomas D Sargent; Trevor Williams
Journal:  Dev Dyn       Date:  2010-04       Impact factor: 3.780

2.  Identification and analysis of a conserved Tcfap2a intronic enhancer element required for expression in facial and limb bud mesenchyme.

Authors:  Weiguo Feng; Jian Huang; Jian Zhang; Trevor Williams
Journal:  Mol Cell Biol       Date:  2007-11-05       Impact factor: 4.272

3.  Rapid Communication: Genome-wide association analyses identify loci associated with colostrum production in Jersey cattle1.

Authors:  Jennifer Nicole Kiser; Macy A Cornmesser; Kevin Gavin; Alea Hoffman; Dale A Moore; Holly L Neibergs
Journal:  J Anim Sci       Date:  2019-03-01       Impact factor: 3.159

4.  Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.

Authors:  George W Woodfield; Yizhen Chen; Thomas B Bair; Frederick E Domann; Ronald J Weigel
Journal:  Genes Chromosomes Cancer       Date:  2010-10       Impact factor: 5.006

5.  Dual association by TFAP2A during activation of the p21cip/CDKN1A promoter.

Authors:  Angelo G Scibetta; Ping-Pui Wong; KaYi V Chan; Monica Canosa; Helen C Hurst
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

6.  The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis.

Authors:  J M Park; T Wu; A R Cyr; G W Woodfield; J P De Andrade; P M Spanheimer; T Li; S L Sugg; G Lal; F E Domann; W Zhang; R J Weigel
Journal:  Oncogene       Date:  2015-03-16       Impact factor: 9.867

7.  Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.

Authors:  Verena Thewes; Francesca Orso; Richard Jäger; Dawid Eckert; Sabine Schäfer; Gregor Kirfel; Stephan Garbe; Daniela Taverna; Hubert Schorle
Journal:  BMC Cancer       Date:  2010-05-11       Impact factor: 4.430

8.  Sumoylation pathway is required to maintain the basal breast cancer subtype.

Authors:  Maria V Bogachek; Yizhen Chen; Mikhail V Kulak; George W Woodfield; Anthony R Cyr; Jung M Park; Philip M Spanheimer; Yingyue Li; Tiandao Li; Ronald J Weigel
Journal:  Cancer Cell       Date:  2014-05-15       Impact factor: 31.743

Review 9.  Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation.

Authors:  Giovanni L Gravina; Claudio Festuccia; Francesco Marampon; Vladimir M Popov; Richard G Pestell; Bianca M Zani; Vincenzo Tombolini
Journal:  Mol Cancer       Date:  2010-11-25       Impact factor: 27.401

10.  Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells.

Authors:  He Ailan; Xiao Xiangwen; Ren Daolong; Gan Lu; Ding Xiaofeng; Qiao Xi; Hu Xingwang; Liu Rushi; Zhang Jian; Xiang Shuanglin
Journal:  BMC Cancer       Date:  2009-08-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.